ParkwayHealth

What ParkwayHealth does

ParkwayHealth (百汇医疗) is a Shanghai-based premium international healthcare provider founded in 2005 and operated as a joint venture between IHH Healthcare Group, Shanghai Hongxin Medical Investment Holding, and Taikang Insurance Group. The company runs a four-facility network anchored by Shanghai Parkway Hospital, a 450-bed comprehensive hospital built with a RMB 1.61 billion investment across 84,400 square meters in the New Hongqiao International Medical Park, supplemented by three outpatient clinics in the Xintiandi, Pudong Biyun, and Changning Gubei districts. Services span 25+ medical specialties ranging from general practice, pediatrics, gynecology, and ENT to advanced specialty centers including the Minimally Invasive Smart Orthopedic Center (featuring the Mako robotic surgery system), the Panvascular Disease Center, the Cancer/Oncology Center, a Health Examination Center, and an Aesthetic Medicine Center.

The underlying technology stack combines advanced clinical equipment (Mako robotic surgery, Histotripsy ultrasound tissue ablation for liver tumors) with digital tools including a Metaverse Lung Nodule Diagnosis Center and CAVE visualization referenced in partnership with HKS Architects for hospital design. The business model operates on a fee-for-service medical services revenue base, augmented by insurance direct billing partnerships (notably MSH/Wan Xin He, where ParkwayHealth is designated a 'non-expensive medical' institution), corporate health examination and visa/study-abroad medical services, and aesthetic medicine. Patient acquisition runs through direct-to-consumer channels (WeChat mini-program, website, dedicated appointment hotline) targeting Shanghai's affluent expatriate community and premium-paying local Chinese residents, alongside enterprise field sales for corporate health packages and event-based medical sponsorships (e.g., Shanghai Rolex Masters). The company achieved designated medical insurance institution status in May 2025, materially expanding its addressable patient base beyond self-pay premium consumers.

ParkwayHealth operates within the IHH Healthcare global network spanning 10+ countries and 80+ hospitals, enabling cross-border referral pathways to Singapore and Hong Kong and access to international clinical expertise. In December 2024, the company announced a brand upgrade and increased investment commitment to China after two decades of operations, signaling a renewed offensive posture in the Chinese premium healthcare market.

Name

ParkwayHealth

Legal name

Parkway China

Website

https://parkwayhealth.cn

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

ParkwayHealth is a Shanghai-based premium international healthcare provider operating a 450-bed hospital and three outpatient clinics, serving affluent expatriates and local Chinese through 25+ specialties, advanced robotic surgery, and insurance direct billing as part of IHH Healthcare's global network.

Ownership category

akta.pro rank

Product category

Premium International Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Hospital-Owned Physician Networks & Medical Groups (HLAFAAAL)

akta.pro secondary industries

Primary Care & General Medicine Virtual Care (HLALAAAA), Cross-Border/Medical Travel Telehealth Marketplaces (HLALALAE), Wellness, Preventive & Executive Health Travel Facilitators (THAKAIAK)

Keywords

• Premium healthcare services
• International hospital network
• Outpatient clinic services
• Specialty medical centers
• Corporate health examinations

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Fee-for-service healthcare delivery across multiple specialty departments including general practice, specialized surgery, aesthetic medicine, and preventive health checkups. Revenue generated from consultation fees, surgical procedures, diagnostic tests, and medication sales.
2. Insurance Direct Pay: Partnership with international insurance providers (MSH, and others) for direct billing services. Revenue collected directly from insurance companies rather than out-of-pocket patient payments, expanding accessibility to insured populations.
3. Corporate Health Services: Enterprise health examination packages, visa medical examinations for immigration purposes, and study abroad health checkup services targeting corporate clients and educational institutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

ParkwayHealth operates a premium international-standard healthcare network in Shanghai comprising a 450-bed flagship hospital (Shanghai Parkway Hospital) and three outpatient clinics (Xintiandi, Pudong Biyun, Changning Gubei). It delivers multi-specialty medical services across 25+ departments, advanced surgical procedures (Mako robotics, Histotripsy), specialty centers (orthopedics, oncology, panvascular, aesthetic medicine), preventive health checkups, vaccination, and overseas physical examinations. The network supports direct billing with international insurance providers such as MSH and recently became a designated medical insurance institution.

Product overview

ParkwayHealth is a premium international healthcare provider operating a network of hospitals and clinics in Shanghai, China. The portfolio consists of Shanghai Parkway Hospital as the flagship comprehensive facility (450 beds, RMB 1.61 billion investment) alongside multiple outpatient clinics (Xintiandi, Pudong Biyun, Changning Gubei). Services include general departments (internal medicine, surgery, pediatrics, gynecology, ENT, orthopedics), Centers of Excellence (orthopedics, aesthetic medicine, dental, women's wellness, telemedicine), and specialty centers (panvascular disease, oncology, minimally invasive orthopedics with Mako robotics, health examination). The network is part of IHH Healthcare and offers international-standard medical services with insurance direct pay and medical insurance coverage.

Differentiator

Problem solved

Functional benefit

Brands

• Shanghai Parkway Hospital (上海百汇医院): General hospital with 450 beds, located in New Hongqiao International Medical Park
• Parkway Xintiandi Medical Center
• Parkway Minimally Invasive Smart Orthopedic Center
• Parkway Medical Aesthetic Medicine Center
• International Remote Medical and Referral Center

Products and services

• Shanghai Parkway Hospital Comprehensive 450-bed flagship hospital co-funded by IHH Healthcare, Shanghai Hongxin Medical Investment, and Taikang Insurance Group in the New Hongqiao International Medical Park, with 84,400 sqm of construction area and a RMB 1.61 billion investment. Provides full multi-specialty inpatient and outpatient services.
• Parkway Xintiandi Medical Center Outpatient and surgery center plus health management and overseas examination center located in Shanghai Plaza, Huangpu District, offering accessible ambulatory services in central Shanghai.
• Parkway Medical Pudong (Biyun Clinic) Outpatient clinic located in the Pudong Jinqiao Biyun Road area serving the eastern Shanghai expatriate community.
• Parkway Medical Changning (Gubei Clinic) Outpatient clinic located in Changning Gubei area serving the western Shanghai expatriate community.
• Minimally Invasive Smart Orthopedics Center Specialized orthopedic center featuring the Mako robotic surgical system for precision knee and hip joint replacement and other minimally invasive orthopedic procedures.
• Panvascular Disease Center Specialized center for panvascular disease diagnosis and treatment using integrated medicine approaches, with Professor Ge Junbo as Chief Scientist.
• Cancer/Oncology Center Oncology center partnered with Professor Ding Gang providing comprehensive cancer diagnosis and treatment services.
• Health Examination Center Premium health examination center offering comprehensive screening, executive checkups, and preventive care services.
• Histotripsy Tissue Dissolution Technology Clinic Non-invasive ultrasound tissue dissolution technology clinic for liver tumor treatment at Shanghai Parkway Hospital, offering a novel non-invasive ablation modality.
• Vaccination Services Comprehensive vaccination services including HPV vaccines for males and females and other routine and travel-related immunizations.
• Overseas Physical Examination Services Medical examination services for visa applications, immigration purposes, and study abroad requirements, including Canada visa medical examinations, producing internationally recognized certificates.
• Night Aesthetic Medicine Clinic Night-time outpatient aesthetic medicine clinic allowing patients to receive cosmetic treatments after work hours.
• Night Surgery Services Night-time surgical services allowing working patients to schedule procedures outside of standard business hours.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• HKS ArchitectscoreStrategic or Co-development Partner · 12 November 2024Architecture and design firm partnership for hospital projects across Asia Pacific. HKS has designed over $10 billion worth of healthcare infrastructure in China and Asia Pacific, currently working on large-scale hospital projects with 450-1,000+ bed capacity incorporating AI integration, pandemic-ready design standards, and CAVE visualization tools.
• IHH HealthcarecoreOthersGlobal private healthcare network operating in 10+ countries with 80+ hospitals. ParkwayHealth is part of the IHH Healthcare service network, providing access to international medical expertise, cross-border referral pathways, and global best practices.
• Shanghai Yueyang HospitalcoreStrategic or Co-development PartnerChinese-Western medicine integration partnership, combining traditional Chinese medicine with modern western medical approaches for comprehensive patient care.
• China Stem Cell Group Affiliated Stem Cell HospitalminorStrategic or Co-development PartnerStrategic cooperation for stem cell therapy research and treatment services, expanding advanced treatment options for patients.
• Chuangqi Health Research InstituteminorStrategic or Co-development PartnerMedical innovation cooperation exploring healthcare system improvements and collaborative research opportunities.
• MSH (Wan Xin He)coreChannel Partner/ Reseller/ DistributorInternational insurance broker providing direct billing services. ParkwayHealth has been included in MSH's 'non-expensive medical' category, expanding access to insured patient populations.
• Shanghai Minhang District Huacao Town Medical Blood Donation ProgramminorOthersParticipation in community blood donation drives and health awareness programs supporting local healthcare needs.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Regional players

• Aier Eye Hospital Group: Aier Eye Hospital is China's largest private specialty hospital chain with a nationwide network of eye hospitals and clinics. While operating in a single specialty rather than ParkwathHealth's general hospital model, it is a relevant scale comparable for Chinese private specialty hospital expansion.
• Phoenix Healthcare Group: Phoenix Healthcare Group is one of China's largest private hospital and clinic networks, operating hospitals and ancillary services across multiple provinces. It is a regional Chinese private healthcare comparable for scale and network structure, though at a different price point than ParkwayHealth.
• Topchoice Medical Corporation: Topchoice Medical is a leading Chinese private specialty hospital and dental service group with a national network. It is a regional Chinese private healthcare provider comparable for capital-intensive specialty medical group expansion, though with a different specialty mix than ParkwayHealth.

Broad incumbents

• Bangkok Dusit Medical Services (BDMS): BDMS is the largest private hospital network in Thailand and a leading Asian medical-tourism destination, offering premium international-standard care across multiple specialty hospitals. It is a broad incumbent in the same premium international hospital category as ParkwayHealth and IHH.
• Aster DM Healthcare: Aster DM Healthcare operates a network of premium hospitals and clinics across the Middle East, India, and Southeast Asia, serving international and medical-tourism patients. It is a broader incumbent competing for the same international patient flows that ParkwayHealth targets via IHH's network.
• IHH Healthcare: Singapore-listed IHH Healthcare is ParkwayHealth's parent company and one of the world's largest private healthcare networks operating 80+ hospitals across 10+ countries including Malaysia, Singapore, Turkey, and India. It is the broader incumbent in the international hospital network space in which ParkwayHealth operates.

Direct peers

• Raffles Medical Group: Raffles Medical Group is a Singapore-headquartered private healthcare provider offering premium international-standard hospital and clinic services across Asia. It directly competes with ParkwayHealth in cross-border patient care, executive health screening, and medical tourism between Singapore and China.
• United Family Healthcare: United Family Healthcare (和睦家) is China's leading premium international-standard hospital network, directly competing with ParkwayHealth for affluent expat and high-income Chinese patients in tier-1 cities including Shanghai. It is the closest direct competitor in the China premium international healthcare segment.
• Bumrungrad International Hospital: Bumrungrad is one of Asia's largest and most recognized international hospitals, treating over a million patients annually including a significant share of international and medical-tourism patients. It is a direct comparator for ParkwayHealth's premium positioning and cross-border patient referral economics.
• Shanghai Jiahui International Hospital: Jiahui International Hospital is a newer premium international-standard hospital in Shanghai, jointly developed with Massachusetts General Hospital. It is a direct competitor aggressively targeting the same affluent expat and Chinese resident segment in Shanghai where ParkwayHealth operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ParkwayHealth